Drug Development Revolution: Top Gun Phd Doctor: Dr. Gennaro D'Urso, PhD, Founder of Genetic Networks, echoed this enthusiasm, stating, "Category V Biotech ($CATV) shares our dedication to leveraging genetics to revolutionize drug development. By joining forces, we envisage broadening the reach and impact of our platform, ultimately delivering superior medicines to patients in need."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.